Trial Profile
Observational, Retrospective and Descriptive Study of Taliglucerase Alfa in Gaucher disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jul 2018
Price :
$35
*
At a glance
- Drugs Taliglucerase alfa (Primary)
- Indications Gaucher's disease type I
- Focus Adverse reactions; Therapeutic Use
- 31 Jul 2018 New trial record